Cargando…
Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma
Ferroptosis is a newly characterized form of iron-dependent non-apoptotic cell death, which is closely associated with cancer progression. However, the functions and mechanisms in regulation of escaping from ferroptosis during hepatocellular carcinoma (HCC) progression remain unknown. In this study,...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064926/ https://www.ncbi.nlm.nih.gov/pubmed/36989117 http://dx.doi.org/10.1080/15592294.2023.2192438 |
_version_ | 1785017998006812672 |
---|---|
author | Zhai, Hang Zhong, Sisi Wu, Runxin Mo, Zhaohong Zheng, Shiyang Xue, Jinhua Meng, Hongyu Liu, Maosheng Chen, Xianyu Zhang, Guangquan Zheng, Xiyan Du, Fei Li, Ruixi Zhou, Boxuan |
author_facet | Zhai, Hang Zhong, Sisi Wu, Runxin Mo, Zhaohong Zheng, Shiyang Xue, Jinhua Meng, Hongyu Liu, Maosheng Chen, Xianyu Zhang, Guangquan Zheng, Xiyan Du, Fei Li, Ruixi Zhou, Boxuan |
author_sort | Zhai, Hang |
collection | PubMed |
description | Ferroptosis is a newly characterized form of iron-dependent non-apoptotic cell death, which is closely associated with cancer progression. However, the functions and mechanisms in regulation of escaping from ferroptosis during hepatocellular carcinoma (HCC) progression remain unknown. In this study, we reported that the RNA binding motif single stranded interacting protein 1 (RBMS1) participated in HCC development,and functioned as a regulator of ferroptosis. Clinically, the downregulation of RBMS1 occurred in HCC tissues, and low RBMS1 expression was associated with worse HCC patients survival. Mechanistically, RBMS1 overexpression inhibited HCC cell growth by attenuating the expression of glutathione peroxidase 4 (GPX4)and further facilitated ferroptosis in vitro and in vivo. More importantly, a novel circIDE (hsa_circ_0000251) was identified to elevate RBMS1 expression via sponging miR-19b-3p in HCC cells. Collectively, our findings established circIDE/miR-19b-3p/RBMS1 axis as a regulator of ferroptosis, which could be a promising therapeutic target and prognostic factor. |
format | Online Article Text |
id | pubmed-10064926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-100649262023-04-01 Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma Zhai, Hang Zhong, Sisi Wu, Runxin Mo, Zhaohong Zheng, Shiyang Xue, Jinhua Meng, Hongyu Liu, Maosheng Chen, Xianyu Zhang, Guangquan Zheng, Xiyan Du, Fei Li, Ruixi Zhou, Boxuan Epigenetics Research Paper Ferroptosis is a newly characterized form of iron-dependent non-apoptotic cell death, which is closely associated with cancer progression. However, the functions and mechanisms in regulation of escaping from ferroptosis during hepatocellular carcinoma (HCC) progression remain unknown. In this study, we reported that the RNA binding motif single stranded interacting protein 1 (RBMS1) participated in HCC development,and functioned as a regulator of ferroptosis. Clinically, the downregulation of RBMS1 occurred in HCC tissues, and low RBMS1 expression was associated with worse HCC patients survival. Mechanistically, RBMS1 overexpression inhibited HCC cell growth by attenuating the expression of glutathione peroxidase 4 (GPX4)and further facilitated ferroptosis in vitro and in vivo. More importantly, a novel circIDE (hsa_circ_0000251) was identified to elevate RBMS1 expression via sponging miR-19b-3p in HCC cells. Collectively, our findings established circIDE/miR-19b-3p/RBMS1 axis as a regulator of ferroptosis, which could be a promising therapeutic target and prognostic factor. Taylor & Francis 2023-03-29 /pmc/articles/PMC10064926/ /pubmed/36989117 http://dx.doi.org/10.1080/15592294.2023.2192438 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Research Paper Zhai, Hang Zhong, Sisi Wu, Runxin Mo, Zhaohong Zheng, Shiyang Xue, Jinhua Meng, Hongyu Liu, Maosheng Chen, Xianyu Zhang, Guangquan Zheng, Xiyan Du, Fei Li, Ruixi Zhou, Boxuan Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma |
title | Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma |
title_full | Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma |
title_fullStr | Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma |
title_full_unstemmed | Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma |
title_short | Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma |
title_sort | suppressing circide/mir-19b-3p/rbms1 axis exhibits promoting-tumour activity through upregulating gpx4 to diminish ferroptosis in hepatocellular carcinoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064926/ https://www.ncbi.nlm.nih.gov/pubmed/36989117 http://dx.doi.org/10.1080/15592294.2023.2192438 |
work_keys_str_mv | AT zhaihang suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT zhongsisi suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT wurunxin suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT mozhaohong suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT zhengshiyang suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT xuejinhua suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT menghongyu suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT liumaosheng suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT chenxianyu suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT zhangguangquan suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT zhengxiyan suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT dufei suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT liruixi suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma AT zhouboxuan suppressingcircidemir19b3prbms1axisexhibitspromotingtumouractivitythroughupregulatinggpx4todiminishferroptosisinhepatocellularcarcinoma |